On October

Limited

(“Jacobi”) entered into a Purchase and Sale Agreement
(the “Jacobi Agreement”) pursuant to which the Company agreed to acquire 5.0% of the issued and outstanding ordinary shares
of Jacobi in consideration of 20,000,000 shares of common stock of the Company (the “Transaction”). The Transaction is expected
to close on October 22, 2021.


 


All
of the offers and sales of securities described above were made to accredited investors and the Company relied upon the exemptions contained
in Section 4(a)(2) of the Securities Act of 1933, as amended, with regard to those sales. No advertising or general solicitation was
employed in offering the securities. The offers and sales were made to a limited number of persons, each of whom was an accredited in vestor
and transfer of the securities issued was restricted by the Company in accordance with the requirements of the Securities Act of 1933.


 




1




 


SIGNATURES


 


Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


 




 


NUKKLEUS
INC.





 


 


 




October
20, 2021


By:


/s/
Emil Assentato




 


 


Name:
Emil Assentato




 


 


Title:
President and Chief Executive Officer




 


 


2



 







makes a similar move, sign up!

Other recent filings from the company include the following:

Nukkleus Inc. Just Filed Its Quarterly Report: Per share data ASC T... - Aug. 1, 2022
Nukkleus Inc. Just Filed Its Quarterly Report: Per share data ASC T... - Aug. 1, 2022
Change in Registrants Certifying - July 29, 2022
Nukkleus Inc. Just Filed Its Annual Report: Per share data ASC T... - July 27, 2022

Auto Refresh

Feedback